March 3, 2020
Fujifilm said on March 2 that its US subsidiary Fujifilm Cellular Dynamics, specializing in the development, manufacture, and commercialization of iPS cells, will commence operations of its new production facility for iPS cells for therapeutic use on March 4. The...read more